Skip to main content

Xenon Pharmaceuticals Inc. insider trading

XENENASDAQ
$36.57-1.00 (-2.66% today)

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price

Insider Trading vs Stock Price data

Showing the 1Y range: Oct 6, 2025 to Oct 6, 2026. Price (-7.5%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
DateCategoryPersonRoleActionAmountChange in holding
Open market purchase
Open market sell
Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium
Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Unlock quarterly net flow

Key players

  • IMIan MortimerPRESIDENT & CEO0.0663%of company
  • DSDawn SvoronosDirector0.0324%of company
  • GPGary PatouDirector0.0308%of company
  • TPThomas Patrick KellyChief Financial Officer0.0155%of company
  • ADAndrea DiFabioChief Legal Officer0.0075%of company
  • CPClarence Patrick MachadoDirector0.0027%of company
  • EAElizabeth A. GarofaloDirector0.0027%of company
  • JDJustin D. GoverDirector0.0027%of company
  • SGSteven GannonDirector0.0019%of company
  • GCGillian CannonDirector0.0015%of company

AI Activity Analysis

Premium
Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto
CompanyInsider / roleActionΔOwnAvg priceAmount
XENEThomas Patrick KellyChief Financial OfficerOpen market purchase$560KNot reported$37.32$560KSep 30, 2026Oct 1, 2026
XENEIan MortimerPRESIDENT & CEOOpen market purchase$1.12M+87.7%$37.38$1.12MSep 30, 2026Oct 1, 2026
XENEChristopher John KenneyChief Medical OfficerOpen market sell$42.7K-99.7%$60.98$42.7KAug 28, 2026Aug 31, 2026
XENEChristopher John KenneyChief Medical OfficerOpen market sell$383K-90.1%$60.17$383KAug 28, 2026Aug 31, 2026
XENESteven GannonDirectorOpen market sell$641K-84.3%$64.06$641KAug 11, 2026Aug 13, 2026
XENEGary PatouDirectorOpen market sell$70.3K-4.3%$53.14$70.3KJun 5, 2026Jun 8, 2026
XENEGillian CannonDirectorOpen market sell$63.2K-45.0%$53.14$63.2KJun 5, 2026Jun 8, 2026
XENEChristopher John KenneyChief Medical OfficerOpen market sell$77.9K-16.6%$55.23$77.9KMar 13, 2026Mar 13, 2026
XENEAndrea DiFabioChief Legal OfficerOpen market sell$74.1K-15.5%$55.23$74.1KMar 13, 2026Mar 13, 2026
XENEIan MortimerPRESIDENT & CEOOpen market sell$404K-17.6%$55.23$404KMar 13, 2026Mar 13, 2026
XENEChristopher John KenneyChief Medical OfficerOpen market sell$167K-37.0%$60.11$167KMar 10, 2026Mar 11, 2026
XENEAndrea DiFabioChief Legal OfficerOpen market sell$157K-34.8%$60.11$157KMar 10, 2026Mar 11, 2026
XENEIan MortimerPRESIDENT & CEOOpen market sell$677K-28.0%$60.11$677KMar 10, 2026Mar 11, 2026
XENEIan MortimerPRESIDENT & CEOOpen market sell$93.1K-9.0%$46.32$93.1KDec 8, 2025Dec 9, 2025
XENEIan MortimerPRESIDENT & CEOOpen market sell$402K-28.3%$45.59$402KDec 8, 2025Dec 9, 2025
XENEIan MortimerPRESIDENT & CEOOpen market sell$647K-31.6%$45.03$647KDec 5, 2025Dec 9, 2025
XENEIan MortimerPRESIDENT & CEOOpen market sell$4.37K-0.2%$45.01$4.37KNov 28, 2025Dec 3, 2025
End of history · 17 transactions

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.